EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX

Katherine A Morgan iD, Christian W Wichmann iD, Laura D Osellame iD, Zhipeng Cao iD, Nancy Guo, Andrew M Scott iD, Paul S Donnelly iD

Chemical Science · 2024 · 15 (9) · 3372-3381

DOI: 10.1039/d3sc06365h ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Science, 2024. Verfasst von Katherine A Morgan und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne Melbourne Australia. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Australian Research Council, Cancer Council Victoria, Australian Cancer Research Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX leads to a highly significant therapeutic response in a mouse xenograft model.

Autor:innen und Institutionen

  • School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne Melbourne Australia.
  • Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute Melbourne Australia.
  • School of Cancer Medicine, La Trobe University Melbourne Australia.
  • Department of Molecular Imaging and Therapy Austin Health Melbourne Australia.
  • Department of Medicine, University of Melbourne Melbourne Australia pauld@unimelb.edu.au.

ORCID-Profile: Katherine A Morgan, Christian W Wichmann, Laura D Osellame, Zhipeng Cao, Andrew M Scott, Paul S Donnelly

Förderung

  • Australian Research Council
  • Cancer Council Victoria
  • Australian Cancer Research Foundation
  • National Health and Medical Research Council

Zitieren

APA

Morgan, K. A., Wichmann, C. W., Osellame, L. D., Cao, Z., Guo, N., Scott, A. M., & Donnelly, P. S. (2024). Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX. Chemical Science, 15(9), 3372-3381. https://doi.org/10.1039/d3sc06365h

Vancouver

Morgan KA, Wichmann CW, Osellame LD, Cao Z, Guo N, Scott AM, et al. Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX. Chemical Science. 2024;15(9):3372-3381. doi:10.1039/d3sc06365h

BibTeX
@article{Morgan2024,
  author = {Morgan, Katherine A and Wichmann, Christian W and Osellame, Laura D and Cao, Zhipeng and Guo, Nancy and Scott, Andrew M and Donnelly, Paul S},
  title = {Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX},
  journal = {Chemical Science},
  year = {2024},
  volume = {15},
  number = {9},
  pages = {3372--3381},
  doi = {10.1039/d3sc06365h}
}
Kostenlos starten →